NCT00588640View on ClinicalTrials.gov

Study of D-Methadone in Patients With Chronic Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
PainBladder CancerBreast CancerCNS CancerColon CancerEsophageal CancerPancreatic CancerProstate CancerUterine CancerHead and Neck CancerEye CancerOtorhinolaryngologic Neoplasms
Interventions
DRUG

d-Methadone

8 subjects to receive 40 mg d-Methadone twice a day

DRUG

D-methadone

After randomization, patients will take the study drug or placebo for 12 days and then they will cross-over to the opposite arm for another 12 days. The study will end on day 24.

DRUG

placebo

After randomization, patients will take the study drug or placebo for 12 days and then they will cross-over to the opposite arm for another 12 days. The study will end on day 24.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00588640 - Study of D-Methadone in Patients With Chronic Pain | Biotech Hunter | Biotech Hunter